title: Effectiveness of azacitidine in higher-risk myelodysplastic syndromes.
authors.affiliation: Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: A G
authors.initials: AG
authors.lastname: Dinmohamed
authors.affiliation: Clinical Trial Center, HOVON Data Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Y
authors.initials: Y
authors.lastname: van Norden
authors.affiliation: Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: A A
authors.initials: AA
authors.lastname: van de Loosdrecht
authors.affiliation: Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Jongen-Lavrencic
mesh_terms: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine; D005006:Ethnicity; D006801:Humans; D009190:Myelodysplastic Syndromes; D012042:Registries
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine